NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave - NV-387 is Effective Against H3N2

Core Viewpoint - The current severe influenza wave highlights the urgent need for broad-spectrum antivirals that can effectively target all influenza viruses and other seasonal respiratory viruses, including RSV and Coronaviruses [1] Company Summary - NanoViricides, Inc. is positioned as a clinical stage leader in the development of innovative broad-spectrum antiviral drugs that are designed to be effective against viruses [1] - The company emphasizes the significance of its antiviral solutions in light of the CDC's classification of this year's flu season as "moderately severe" [1]